nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association between RCT methodology and disease indication with mineralocorticoid-related toxicity for patients receiving abiraterone acetate for advanced prostate cancer: A meta-analysis of RCTs
|
Hall, Mary E. |
|
|
21 |
5 |
p. e370-e377 |
artikel |
2 |
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma
|
Dizman, Nazli |
|
|
21 |
5 |
p. 530-536 |
artikel |
3 |
Cardiovascular Adverse Events Associated With New-Generation Androgen Receptor Pathway Inhibitors (ARPI) for Prostate Cancer: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS)
|
Liu, Yang |
|
|
21 |
5 |
p. 594-601.e2 |
artikel |
4 |
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)
|
Santoni, Matteo |
|
|
21 |
5 |
p. e309-e319.e1 |
artikel |
5 |
Comprehensive Analyses Revealed Eight Immune Related Signatures Correlated With Aberrant Methylations as Prognosis and Diagnosis Biomarkers for Kidney Renal Papillary Cell Carcinoma
|
Luo, Yueji |
|
|
21 |
5 |
p. 537-545 |
artikel |
6 |
Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States
|
Lai, Yizhen |
|
|
21 |
5 |
p. 612.e1-612.e11 |
artikel |
7 |
Editorial Board
|
|
|
|
21 |
5 |
p. A1 |
artikel |
8 |
Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer
|
Chávarri-Guerra, Yanin |
|
|
21 |
5 |
p. 569-573 |
artikel |
9 |
High Infiltration of CD163-Positive Macrophages in Intratumor Compartment Predicts Poor Prognosis in Patients With Upper Urinary Tract Urothelial Carcinoma and Radical Nephroureterectomy
|
Kobayashi, Yasuyuki |
|
|
21 |
5 |
p. e386-e393 |
artikel |
10 |
Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin
|
Jindal, Tanya |
|
|
21 |
5 |
p. e394-e404 |
artikel |
11 |
Impact of Therapy Management on Axitinib-Related Adverse Events in Patients With Advanced Renal Cell Carcinoma Receiving First-Line Axitinib + Checkpoint Inhibitor
|
Zakharia, Yousef |
|
|
21 |
5 |
p. e343-e351 |
artikel |
12 |
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group
|
Douglawi, Antoin |
|
|
21 |
5 |
p. 563-568 |
artikel |
13 |
Intraoperative Frozen Section via Neurosafe During Robotic Radical Prostatectomy in the Era of Preoperative Risk Stratifications and Primary Staging With mpMRI and PSMA-PET CT: Is There a Perfect Candidate?
|
Köseoğlu, Ersin |
|
|
21 |
5 |
p. 602-611 |
artikel |
14 |
Management of Localized Prostate Cancer in Men With Human Immunodeficiency Virus: Analysis of a Large Retrospective Cohort
|
Vaziri, Tina |
|
|
21 |
5 |
p. 614.e1-614.e8 |
artikel |
15 |
Patterns of Utilization and Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced-urothelial Bladder Cancer (LABC)-Real World Data From an Indian Tertiary Care Cancer Center
|
Saravanabavan, Srivishnu |
|
|
21 |
5 |
p. e326-e333 |
artikel |
16 |
Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer
|
Gamba, Teresa |
|
|
21 |
5 |
p. 509-516 |
artikel |
17 |
Predictors of Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis
|
Ferro, Matteo |
|
|
21 |
5 |
p. 574-583 |
artikel |
18 |
Prognostic Value of Inflammation Biomarkers in Penile Squamous Cell Carcinoma Patients Without Distant Metastasis
|
Xue, Ting |
|
|
21 |
5 |
p. e334-e342.e1 |
artikel |
19 |
Real-World Treatment Patterns Among French Patients With Metastatic Castration-Resistant Prostate Cancer Under Abiraterone or Enzalutamide
|
SCAILTEUX, Lucie-Marie |
|
|
21 |
5 |
p. e362-e369 |
artikel |
20 |
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience
|
Bakaloudi, Dimitra Rafailia |
|
|
21 |
5 |
p. 584-593 |
artikel |
21 |
Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808
|
Carthon, Bradley C. |
|
|
21 |
5 |
p. 546-554 |
artikel |
22 |
Salvage Cryoablation for Recurrent Prostate Cancer Following Primary External Beam Radiotherapy or Primary Cryotherapy: A Propensity Score Matched Analysis of Mid-term Oncologic and Functional Outcomes
|
Campbell, Scott P. |
|
|
21 |
5 |
p. 555-562 |
artikel |
23 |
Single-Dose Post-Office Fulguration Mitomycin C Instillation Appears to Improve Recurrence-Free Survival in Patients With Low-Grade Noninvasive Bladder Cancer
|
Halstuch, Daniel |
|
|
21 |
5 |
p. e320-e325 |
artikel |
24 |
Table of contents
|
|
|
|
21 |
5 |
p. A3-A8 |
artikel |
25 |
The Efficacy of Presurgical Therapy With Avelumab and Axitinib for Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus
|
Tobe, Taisuke |
|
|
21 |
5 |
p. 613.e1-613.e6 |
artikel |
26 |
The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial Carcinoma
|
Pierantoni, Francesco |
|
|
21 |
5 |
p. e378-e385 |
artikel |
27 |
Treatment Patterns, Clinical Outcomes, Health Care Resource Utilization and Costs in Older Patients With Metastatic Castration-Resistant Prostate Cancer in the United States: An Analysis of SEER-Medicare Data
|
Swami, Umang |
|
|
21 |
5 |
p. 517-529 |
artikel |
28 |
Tumoral Ki67 and PSMA Expression in Fresh Pre-PSMA-RLT Biopsies and Its Relation With PSMA-PET Imaging and Outcomes of PSMA-RLT in Patients With mCRPC
|
Laarhuis, Babette I. |
|
|
21 |
5 |
p. e352-e361 |
artikel |
29 |
Very Long‐Term Complete Remission Can Be Achieved in Men With High‐Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial
|
Orlando, Valentina |
|
|
21 |
5 |
p. 615.e1-615.e8 |
artikel |